GEN-Thermo_Oct22_MakingThePromiseOf - 23

Count on a partner who knows the way
Accelerate mRNA vaccine and therapeutics production from preclinical development
to commercialization with the Thermo Scientific™
TheraPure™
GMP*
portfolio. It
includes restriction enzymes, in vitro transcription enzymes, nucleotides, and other
reaction components that are designed to meet critical process, scale, quality, and
regulatory needs.
Technical partnership
In-field support on process
Quality at scale
development, scale-up, and
commercial manufacturing
Seamless progression from
preclinical development to
commercial manufacturing
and regulatory submission
Proven products
Used in the manufacturing
of many clinical and
commercial mRNA vaccines
and therapeutics
Partner with us to help accelerate the commercialization of your mRNA vaccines
and therapeutics
* " TheraPure GMP " refers to the quality level of the raw, ancillary, or starting materials to be used for further manufacturing. TheraPure
GMP products are manufactured in facilities with ISO 9001-certified quality management systems operating in accordance with relevant
good manufacturing practice (GMP) principles as outlined in ICH Q7 or equivalent guidance documents or standards.
Contact us at thermofisher.com/therapure
For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into
humans or animals. © 2022 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the
property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. COL119187 0922

https://www.thermofisher.com/us/en/home.html https://www.thermofisher.com/us/en/home/industrial/pharma-biopharma/nucleic-acid-therapeutic-development-solutions/mrna-therapeutic-resources/mrna-synthesis-reagents.html?cid=fl-therapure

GEN-Thermo_Oct22_MakingThePromiseOf

Table of Contents for the Digital Edition of GEN-Thermo_Oct22_MakingThePromiseOf